Assessment of leucoreduction of sickle cell trait blood: quality of the filtered product.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: SIMTI servizi Country of Publication: Italy NLM ID: 101237479 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2385-2070 (Electronic) Linking ISSN: 17232007 NLM ISO Abbreviation: Blood Transfus Subsets: MEDLINE
    • Publication Information:
      Original Publication: Milano : SIMTI servizi
    • Subject Terms:
      Leukocyte Reduction Procedures*/methods; Sickle Cell Trait/*blood; Air ; Anticoagulants/pharmacology ; Blood Donors ; Blood Preservation ; Blood Volume ; Citrates/pharmacology ; Erythrocyte Deformability ; Female ; Hemoglobins/analysis ; Hemolysis ; Humans ; Leukocyte Count ; Male ; Oxygen/pharmacology ; Sampling Studies
    • Abstract:
      Background: With the implementation of universal leucoreduction of blood components in several industrialised countries, the problems associated with leucocyte filtration of sickle cell trait blood have been reconsidered. In this study, we assessed the use of high performance filters for leucoreduction of packed red blood cells donated from subjects with sickle cell trait and evaluated the incidence and recurrence of altered red blood cell filterability.
      Materials and Methods: Twenty-one volunteer donors with HbAS were compared to 21 donors with HbAA selected at random. The main parameters analysed were residual white blood cell count and post-filtration haemolysis. Filtration times, flow, volume and haemoglobin loss of the packed red blood cells were also determined.
      Results: In all, 33% of HbAS red blood cell units with slow flow and prolonged filtration time had high residual white blood cell counts. In 7.7% of cases, despite flow through the filter, the units were not leucoreduced properly. Haemoglobin and volume loss were significantly greater in the slow filtration group. Significant post-filtration haemolysis was present in half of the units with high residual white blood cell counts.
      Discussion: Despite the development of new technology for filtration, the problem of filterability of blood from donors with sickle cell trait is not yet resolved. Altered filterability of blood from sickle cell trait donors cannot be predicted from the donors' characteristics and recurrence of the problem is not observed between donations. Screening blood donors for sickle cell trait to ensure the safety and quality of blood products for transfusion does, therefore, remain a relevant issue.
    • References:
      Transfusion. 1974 Sep-Oct;14(5):447-52. (PMID: 4411925)
      Transfus Med Rev. 2004 Jul;18(3):168-76. (PMID: 15248166)
      Transfusion. 2007 Dec;47(12):2233-41. (PMID: 17714416)
      Br J Haematol. 2003 Aug;122(4):678-81. (PMID: 12899724)
      Transfusion. 2004 Mar;44(3):422-30. (PMID: 14996202)
      Transfusion. 1994 Jan;34(1):84. (PMID: 8273138)
      Transfus Med. 2006 Aug;16(4):248-53. (PMID: 16879152)
      Transfusion. 2002 Nov;42(11):1466-72. (PMID: 12421220)
      Vox Sang. 1997;73(1):55-6. (PMID: 9269075)
      Transfus Apher Sci. 2001 Apr;24(2):223-5. (PMID: 11501573)
      Transfus Clin Biol. 1996;3(4):225-33. (PMID: 8933676)
      Transfusion. 2004 Sep;44(9):1293-9. (PMID: 15318851)
      Transfusion. 2007 Apr;47(4):687-96. (PMID: 17381628)
    • Accession Number:
      0 (Anticoagulants)
      0 (Citrates)
      0 (Hemoglobins)
      S88TT14065 (Oxygen)
    • Publication Date:
      Date Created: 20121115 Date Completed: 20141112 Latest Revision: 20211021
    • Publication Date:
      20221213
    • Accession Number:
      PMC3934245
    • Accession Number:
      10.2450/2012.0084-12
    • Accession Number:
      23149143